The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: a critical and comprehensive review

RR Girgis, AW Zoghbi, DC Javitt… - Journal of psychiatric …, 2019 - Elsevier
Since the discovery of chlorpromazine in the 1950's, antipsychotic drugs have been the
cornerstone of treatment of schizophrenia, and all attenuate dopamine transmission at the …

Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects

RF Nasyrova, DV Ivashchenko, MV Ivanov… - Frontiers in …, 2015 - frontiersin.org
Currently, schizophrenia is considered a multifactorial disease. Over the past 50 years,
many investigators have considered the role of toxic free radicals in the etiology of …

Comparison of saffron versus fluoxetine in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial

L Kashani, S Eslatmanesh, N Saedi… - …, 2017 - thieme-connect.com
Introduction: Postpartum depression is a common mental health problem that is associated
with maternal suffering. The aim of this double-blind clinical trial was to compare safety and …

Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double‐blind, placebo‐controlled trial

A Zeinoddini, M Sorayani, E Hassanzadeh… - Depression and …, 2015 - Wiley Online Library
Background The antidepressive effect of pioglitazone has been noted in patients with major
depressive disorder in absence of metabolic syndrome. This study was conducted to …

Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial

S Arabzadeh, N Ameli, A Zeinoddini, F Rezaei… - Bipolar …, 2015 - Wiley Online Library
Objectives Recent research has focused on the inflammatory cascade as a key culprit in the
etiology of bipolar disorder. We hypothesized that celecoxib, via its anti‐inflammatory …

Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial

H Emadi-Kouchak, P Mohammadinejad… - International clinical …, 2016 - journals.lww.com
Patients with the HIV infection are at high risk for developing depression. The aim of this
study was to investigate the safety and efficacy of antidepressant effects of minocycline on …

Construction of an Exudative Age-Related Macular Degeneration Diagnostic and Therapeutic Molecular Network Using Multi-Layer Network Analysis, a Fuzzy Logic …

H Latifi-Navid, A Barzegar Behrooz, S Jamehdor… - Pharmaceuticals, 2023 - mdpi.com
Neovascular age-related macular degeneration (nAMD) is a leading cause of irreversible
visual impairment in the elderly. The current management of nAMD is limited and involves …

Riluzole combination therapy for moderate-to-severe major depressive disorder: a randomized, double-blind, placebo-controlled trial

E Salardini, A Zeinoddini, P Mohammadinejad… - Journal of psychiatric …, 2016 - Elsevier
Recent evidences suggest that glutamatergic dysregulation implicated in neural plasticity
and cellular resilience may contribute to the pathophysiology of Major Depressive Disorder …

Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial

A Ghaleiha, R Alikhani, MR Kazemi… - Journal of child and …, 2016 - liebertpub.com
Objective: This is an investigation of minocycline efficacy and safety as an adjuvant to
risperidone in management of children with autism. Methods: Forty-six children with …

Efficacy and safety of celecoxib monotherapy for mild to moderate depression in patients with colorectal cancer: A randomized double-blind, placebo controlled trial

M Alamdarsaravi, A Ghajar, AA Noorbala, M Arbabi… - Psychiatry …, 2017 - Elsevier
Cancer-related inflammation is an essential process in malignancies. Celecoxib, a
nonsteroidal anti-inflammatory drug that acts via the selective inhibition of cyclooxygenase …